Intestinal mast cells in gut inflammation and motility disturbances

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 1, 2012, Pages 66-73

  De Winter, Benedicte Y ^a   van den Wijngaard, Rene M ^b   de Jonge, Wouter J ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

IBD; Ileus; Macrophages; Mast cells; Motility; Neurogastroenterology

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DOXANTRAZOLE; INTERLEUKIN 10; KETOTIFEN; MESALAZINE; METHOTREXATE; PLACEBO; STEROID; SUBSTANCE P;

ANIMAL MODEL; CELL ACTIVATION; CLINICAL FEATURE; COLITIS; COLLAGENOUS COLITIS; CROHN DISEASE; ENTERITIS; EPIDURAL ANESTHESIA; GASTROINTESTINAL TRACT; HUMAN; IMMUNE RESPONSE; INTESTINE CELL; INTESTINE FUNCTION; MAST CELL; MAST CELL DEGRANULATION; NEUROIMMUNOLOGY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEROID THERAPY; STOMACH PARESIS; ULCERATIVE COLITIS;

ANIMALS; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; ILEUS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MAST CELLS; MUCOUS MEMBRANE; NEUROIMMUNOMODULATION; PERMEABILITY; POSTOPERATIVE COMPLICATIONS;

EID: 82955249099     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.03.016     Document Type: Review

References (92)

1. Artinyan A., Nunoo-Mensah J.W., Balasubramaniam S., Gauderman J., Essani R., Gonzalez-Ruiz C., Kaiser A.M., Beart R.W. Prolonged postoperative ileus-definition, risk factors, and predictors after surgery. World J. Surg. 2008, 32:1495.
2. Barbara G., Stanghellini V., De G.R., Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol. Motil. 2006, 18:6.
3. Barbara G., Wang B., Stanghellini V., De G.R., Cremon C., Di N.G., Trevisani M., Campi B., Geppetti P., Tonini M., Bunnett N.W., Grundy D., Corinaldesi R. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132:26.
4. Bauer A.J. Mentation on the immunological modulation of gastrointestinal motility. Neurogastroenterol. Motil. 2008, 20(Suppl 1):81.
5. Befus A.D., Pearce F.L., Gauldie J., Horsewood P., Bienenstock J. Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells. J. Immunol. 1982, 128:2475.
6. Befus A.D., Pearce F.L., Goodacre R., Bienenstock J. Unique functional characteristics of mucosal mast cells. Adv. Exp. Med. Biol. 1982, 149:521.
7. Ben-Horin S., Chowers Y. Neuroimmunology of the gut: physiology, pathology, and pharmacology. Curr. Opin. Pharmacol. 2008, 8:490.
8. Bienenstock J., MacQueen G., Sestini P., Marshall J.S., Stead R.H., Perdue M.H. Mast cell/nerve interactions in vitro and in vivo. Am. Rev. Respir. Dis. 1991, 143:S55-S58.
9. Bischoff S.C. Physiological and pathophysiological functions of intestinal mast cells. Semin. Immunopathol. 2009, 31:185.
10. Bischoff S.C., Lorentz A., Schwengberg S., Weier G., Raab R., Manns M.P. Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut 1999, 44:643.
11. Boeckxstaens G.E., de Jonge W.J. Neuroimmune mechanisms in postoperative ileus. Gut 2009, 58:1300.
12. Chichlowski M., Westwood G.S., Abraham S.N., Hale L.P. Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS One 2010, 5:e12220.
13. Coldwell J.R., Phillis B.D., Sutherland K., Howarth G.S., Blackshaw L.A. Increased responsiveness of rat colonic splanchnic afferents to 5-HT after inflammation and recovery. J. Physiol. 2007, 579:203.
14. De Filippis D., D'Amico A., Cinelli M.P., Esposito G., Di Marzo V., Iuvone T. Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats. J. Cell. Mol. Med. 2009, 13:1086.
15. de Haan J.J., Lubbers T., Hadfoune M., Luyer M.D., Dejong C.H., Buurman W.A., Greve J.W. Postshock intervention with high-lipid enteral nutrition reduces inflammation and tissue damage. Ann. Surg. 2008, 248:842.
16. de Haan J.J., Thuijls G., Lubbers T., Hadfoune M., Reisinger K., Heineman E., Greve J.W., Buurman W.A. Protection against early intestinal compromise by lipid-rich enteral nutrition through cholecystokinin receptors. Crit. Care Med. 2010, 38:1592.
17. de Jonge W.J., The F.O., van der C.D., Bennink R.J., Reitsma P.H., van Deventer S.J., van den Wijngaard R.M., Boeckxstaens G.E. Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology 2004, 127:535.
18. de Jonge W.J., van den Wijngaard R.M., The F.O., ter Beek M.L., Bennink R.J., Tytgat G.N., Buijs R.M., Reitsma P.H., van Deventer S.J., Boeckxstaens G.E. Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology 2003, 125:1137.
19. De Schepper H.U., De Man J.G., Moreels T.G., Pelckmans P.A., De Winter B.Y. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease-clinical relevance and pathophysiological mechanisms. Aliment. Pharmacol. Ther. 2008, 27:621.
20. De Winter B.Y., Boeckxstaens G.E., De Man J.G., Moreels T.G., Herman A.G., Pelckmans P.A. Effect of adrenergic and nitrergic blockade on experimental ileus in rats. Br. J. Pharmacol. 1997, 120:464.
21. De Winter B.Y., De Man J.G. Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility. World J. Gastroenterol. 2010, 16:5523.
22. Delaney C.P. Clinical perspective on postoperative ileus and the effect of opiates. Neurogastroenterol. Motil. 2004, 16(Suppl 2):61.
23. Derikx J.P., van Waardenburg D.A., Thuijls G., Willigers H.M., Koenraads M., van Bijnen A.A., Heineman E., Poeze M., Ambergen T., van O.A., van Rhijn L.W., Buurman W.A. New insight in loss of gut barrier during major non-abdominal surgery. PLoS One 2008, 3:e3954.
24. Echtenacher B., Mannel D.N., Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75.
25. Eliakim R., Karmeli F., Okon E., Rachmilewitz D. Ketotifen effectively prevents mucosal damage in experimental colitis. Gut 1992, 33:1498.
26. Eliakim R., Rachmilewitz D. Inflammatory mediators and the pathogenesis of inflammatory bowel disease. Ital. J. Gastroenterol. 1992, 24:361.
27. Enerback L., Lundin P.M. Ultrastructure of mucosal mast cells in normal and compound 48-80-treated rats. Cell Tissue Res. 1974, 150:95.
28. Engel D.R., Koscielny A., Wehner S., Maurer J., Schiwon M., Franken L., Schumak B., Limmer A., Sparwasser T., Hirner A., Knolle P.A., Kalff J.C., Kurts C. T helper type 1 memory cells disseminate postoperative ileus over the entire intestinal tract. Nat. Med. 2010, 16:1407.
29. Eskandari M.K., Kalff J.C., Billiar T.R., Lee K.K., Bauer A.J. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am. J. Physiol. 1997, 273:G727-G734.
30. Eskandari M.K., Kalff J.C., Billiar T.R., Lee K.K., Bauer A.J. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am. J. Physiol. 1999, 277:G478-G486.
31. Fabriek B.O., van B.R., Deng D.M., Ligtenberg A.J., Nazmi K., Schornagel K., Vloet R.P., Dijkstra C.D., van den Berg T.K. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009, 113:887.
32. Flores-Langarica A., Meza-Perez S., Calderon-Amador J., Estrada-Garcia T., Macpherson G., Lebecque S., Saeland S., Steinman R.M., Flores-Romo L. Network of dendritic cells within the muscular layer of the mouse intestine. Proc. Natl. Acad. Sci. USA 2005, 102:19039.
33. Fox C.C., Moore W.C., Lichtenstein L.M. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. Dig. Dis. Sci. 1991, 36:179.
34. Fukumoto Y., Kasai H., Takahashi H., Sugiyama H., Hase N., Kaneko H., Hamamura I., Aoki Y., Ota M., Kobayashi T., Katsuura Y., Kamimura T., Komoriya K. The role of mast cells in the development of 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in rats. Scand. J. Gastroenterol. 2002, 37:555.
35. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008, 8:478.
36. Galli S.J., Tsai M., Gordon J.R., Geissler E.N., Wershil B.K. Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci. Ann. N.Y. Acad. Sci. 1992, 664:69.
37. Goldsmith P., McGarity B., Walls A.F., Church M.K., Millward-Sadler G.H., Robertson D.A. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig. Dis. Sci. 1990, 35:1409.
38. He S.H. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J. Gastroenterol. 2004, 10:309.
39. Holzer P. Role of visceral afferent neurons in mucosal inflammation and defense. Curr. Opin. Pharmacol. 2007, 7:563.
40. Iba Y., Sugimoto Y., Kamei C. Participation of mast cells in colitis inflammation induced by dextran sulfate sodium. Methods Find. Exp. Clin. Pharmacol. 2002, 24:15.
41. Jones N.L., Roifman C.M., Griffiths A.M., Sherman P. Ketotifen therapy for acute ulcerative colitis in children: a pilot study. Dig. Dis. Sci. 1998, 43:609.
42. Kageyama-Yahara N., Suehiro Y., Yamamoto T., Kadowaki M. IgE-induced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. Biochem. Biophys. Res. Commun. 2008, 377:321.
43. Kalff J.C., Buchholz B.M., Eskandari M.K., Hierholzer C., Schraut W.H., Simmons R.L., Bauer A.J. Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 1999, 126:498.
44. Kalff J.C., Carlos T.M., Schraut W.H., Billiar T.R., Simmons R.L., Bauer A.J. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 1999, 117:378.
45. Kalff J.C., Turler A., Schwarz N.T., Schraut W.H., Lee K.K., Tweardy D.J., Billiar T.R., Simmons R.L., Bauer A.J. Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy. Ann. Surg. 2003, 237:301.
46. Kehlet H. Postoperative ileus-an update on preventive techniques. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5:552.
47. Kleinschmidt S., Harder J., Nolte I., Marsilio S., Hewicker-Trautwein M. Chronic inflammatory and non-inflammatory diseases of the gastrointestinal tract in cats: diagnostic advantages of full-thickness intestinal and extraintestinal biopsies. J. Feline Med. Surg. 2010, 12:97.
48. Kreiss C., Toegel S., Bauer A.J. Alpha2-adrenergic regulation of NO production alters postoperative intestinal smooth muscle dysfunction in rodents. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G658-G666.
49. Lakhan S.E., Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J. Neuroinflammation 2010, 7:37.
50. Loureiro R.M., Monaco K.A., Kearney J.B., Blickarz-Durand C.E., Kirby S.L., Inamdar M.S., Bautch V.L. csf1 is required for early embryonic macrophage development: characterization of the csf1(op)/csf1(op) mutation in ES cell-derived macrophages. Br. J. Haematol. 2008, 141:739.
51. Lubbers T., Luyer M.D., de Haan J.J., Hadfoune M., Buurman W.A., Greve J.W. Lipid-rich enteral nutrition reduces postoperative ileus in rats via activation of cholecystokinin-receptors. Ann. Surg. 2009, 249:481.
52. MacFie J., O'Boyle C., Mitchell C.J., Buckley P.M., Johnstone D., Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999, 45:223.
53. MacFie J., Reddy B.S., Gatt M., Jain P.K., Sowdi R., Mitchell C.J. Bacterial translocation studied in 927 patients over 13years. Br. J. Surg. 2006, 93:87.
54. MacQueen G., Marshall J., Perdue M., Siegel S., Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989, 243:83.
55. Marshall J.K., Irvine E.J. Ketotifen treatment of active colitis in patients with 5-aminosalicylate intolerance. Can. J. Gastroenterol. 1998, 12:273.
56. McDermott J.R., Bartram R.E., Knight P.A., Miller H.R., Garrod D.R., Grencis R.K. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc. Natl. Acad. Sci. USA 2003, 100:7761.
57. McMenamin C.C., Gault E.A., Haig D.M. The effect of dexamethasone on growth and differentiation of bone-marrow derived mucosal mast cells in vitro. Immunology 1987, 62:29.
58. Menozzi A., Pozzoli C., Poli E., Lazzaretti M., Grandi D., Coruzzi G. Long-term study of TNBS-induced colitis in rats: focus on mast cells. Inflamm. Res. 2006, 55:416.
59. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., Tsai M., Galli S.J. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006, 313:526.
60. Mikkelsen H.B. Macrophages in the external muscle layers of mammalian intestines. Histol. Histopathol. 1995, 10:719.
61. Mikkelsen H.B., Larsen J.O., Hadberg H. The macrophage system in the intestinal muscularis externa during inflammation: an immunohistochemical and quantitative study of osteopetrotic mice. Histochem. Cell Biol. 2008, 130:363.
62. Moriez R., Leveque M., Salvador-Cartier C., Barreau F., Theodorou V., Fioramonti J., Bueno L., Eutamene H. Mucosal mast cell proteases are involved in colonic permeability alterations and subsequent bacterial translocation in endotoxemic rats. Shock 2007, 28:118.
63. O'Boyle C.J., MacFie J., Mitchell C.J., Johnstone D., Sagar P.M., Sedman P.C. Microbiology of bacterial translocation in humans. Gut 1998, 42:29.
64. Podolsky D.K. The current future understanding of inflammatory bowel disease. Best Pract. Res. Clin. Gastroenterol. 2002, 16:933.
65. Raithel M., Winterkamp S., Pacurar A., Ulrich P., Hochberger J., Hahn E.G. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand. J. Gastroenterol. 2001, 36:174.
66. Reddy B.S., Gatt M., Sowdi R., MacFie J. Surgical manipulation of the large intestine increases bacterial translocation in patients undergoing elective colorectal surgery. Colorectal Dis. 2006, 8:596.
67. Rijnierse A., Nijkamp F.P., Kraneveld A.D. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol. Ther. 2007, 116:207.
68. Rodewald H.R., Dessing M., Dvorak A.M., Galli S.J. Identification of a committed precursor for the mast cell lineage. Science 1996, 271:818.
69. Santos J., Perdue M.H. Stress and neuroimmune regulation of gut mucosal function. Gut 2000, 47(Suppl 4):iv49-iv51.
70. Sasaki Y., Tanaka M., Kudo H. Differentiation between ulcerative colitis and Crohn's disease by a quantitative immunohistochemical evaluation of T lymphocytes, neutrophils, histiocytes and mast cells. Pathol. Int. 2002, 52:277.
71. Schwarz N.T., Beer-Stolz D., Simmons R.L., Bauer A.J. Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis. Ann. Surg. 2002, 235:31.
72. Schwarz N.T., Engel B., Eskandari M.K., Kalff J.C., Grandis J.R., Bauer A.J. Lipopolysaccharide preconditioning and cross-tolerance: the induction of protective mechanisms for rat intestinal ileus. Gastroenterology 2002, 123:586.
73. Serna H., Porras M., Vergara P. Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat. J. Pharmacol. Exp. Ther. 2006, 319:1104.
74. Sharkey K.A., Kroese A.B. Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. Anat. Rec. 2001, 262:79.
75. Sharkey K.A., Mawe G.M. Neuroimmune and epithelial interactions in intestinal inflammation. Curr. Opin. Pharmacol. 2002, 2:669.
76. Smythies L.E., Sellers M., Clements R.H., Mosteller-Barnum M., Meng G., Benjamin W.H., Orenstein J.M., Smith P.D. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 2005, 115:66.
77. S.A.Snoek, K.S.Borensztajn, R.M.van den Wijngaard, and W.J.de Jonge, Neuropeptide Receptors in Intestinal Disease: Physiology and Therapeutic Potential, Curr. Pharm. Des (2009).
78. Stead R.H., Colley E.C., Wang B., Partosoedarso E., Lin J., Stanisz A., Hillsley K. Vagal influences over mast cells. Auton. Neurosci. 2006, 125:53.
79. Sudheer P.S., Hall J.E., Donev R., Read G., Rowbottom A., Williams P.E. Nicotinic acetylcholine receptors on basophils and mast cells. Anaesthesia 2006, 61:1170.
80. The F.O., Bennink R.J., Ankum W.M., Buist M.R., Busch O.R., Gouma D.J., van der H.S., van den Wijngaard R.M., de Jonge W.J., Boeckxstaens G.E. Intestinal handling-induced mast cell activation and inflammation in human postoperative ileus. Gut 2008, 57:33.
81. The F.O., Buist M.R., Lei A., Bennink R.J., Hofland J., van den Wijngaard R.M., de Jonge W.J., Boeckxstaens G.E. The role of mast cell stabilization in treatment of postoperative ileus: a pilot study. Am. J. Gastroenterol. 2009, 104:2257.
82. Tremaine W.J., Brzezinski A., Katz J.A., Wolf D.C., Fleming T.J., Mordenti J., Strenkoski-Nix L.C., Kurth M.C. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment. Pharmacol. Ther. 2002, 16:407.
83. Turler A., Kalff J.C., Moore B.A., Hoffman R.A., Billiar T.R., Simmons R.L., Bauer A.J. Leukocyte-derived inducible nitric oxide synthase mediates murine postoperative ileus. Ann. Surg. 2006, 244:220.
84. Turler A., Schnurr C., Nakao A., Togel S., Moore B.A., Murase N., Kalff J.C., Bauer A.J. Endogenous endotoxin participates in causing a panenteric inflammatory ileus after colonic surgery. Ann. Surg. 2007, 245:734.
85. van Berge Henegouwen M.I., Test P.T. Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications. Am. J. Surg. 1998, 175:311.
86. Van Nassauw L., Adriaensen D., Timmermans J.P. The bidirectional communication between neurons and mast cells within the gastrointestinal tract. Auton. Neurosci. 2007, 133:91.
87. Varadaradjalou S., Feger F., Thieblemont N., Hamouda N.B., Pleau J.M., Dy M., Arock M. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 2003, 33:899.
88. Wessler I., Kilbinger H., Bittinger F., Unger R., Kirkpatrick C.J. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci. 2003, 72:2055.
89. Wood J.D. Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies. Gut 2006, 55:445.
90. Wood J.D. Neuropathophysiology of functional gastrointestinal disorders. World J. Gastroenterol. 2007, 13:1313.
91. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427.
92. Xu X., Weksler-Zangen S., Pikarsky A., Pappo O., Wengrower D., Bischoff S.C., Pines M., Rivkind A., Goldin E., Levi-Schaffer F. Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand. J. Gastroenterol. 2002, 37:330.